MedTrace Logo

Evaluating the Symbicort Turbuhaler (Formoterol/Budesonide) Maintenance and Reliever Therapy for Asthma in Daily Practice

NCT00782314 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2009-07-24

No results posted yet for this study

Summary

We want to evaluate efficacy of Symbicort® Turbuhaler® (formoterol/budesonide) therapy for asthma in real life conditions. For this purpose we will include both patients that are treated with Symbicort® Turbuhaler® the "classical" maintenance only treatment approach as well as those treated with the SMART approach.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Igor Koren, MD, MSc · Radix - medicinske storitve, Igor Koren s.p.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Completion
2009-04-30

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00782314 on ClinicalTrials.gov